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Background
TB kills 1.3 million persons annually, including 275,000
people in India. An estimated 40% of the population in
India has LTBI (Latent Tuberculosis Infection), a signifi-
cant percentage of them being infected with HIV. HIV
infection increases the likelihood of LTBI progressing to
active TB. Vaccination and immunotherapeutic strate-
gies are alternative approaches that contribute greatly to
TB control in HIV+ persons with LTBI.
Methods
Peripheral blood was drawn from, HIV+ and HIV- indivi-
duals with and without LTBI. PBMC and CD14+ mono-
cytes were isolated and 2 million cells were cultured with g
irradiated M. tuberculosis H37Rv, CFP-10. Cultures were
terminated after 96 hours, and cells were stained for CD4,
CD25, FOXP3 and D4GDI. IFN-g, IL-17, IL-22 were esti-
mated in the supernatants by ELISA. RNA was isolated
from CD14 cells and Realtime PCR was performed to
quantitate c-maf expression. P<0.05 was considered statisti-
cally significant.
Results
In response to M. tuberculosis, FoxP3+ cells expand in
HIV+ and healthy LTBI+ donors. In contrast, D4GDI+
FoxP3+ cells expand only in healthy LTBI+ individuals.
IL-17 and IL-22 are significantly high in HIV-LTBI+ indi-
viduals, increased c-maf expression in monocytes was
observed in HIV+ LTBI+ individuals
Conclusions
IL-17 and IL-22 can be helpful to control reactivation of
tuberculosis in HIV+ individuals.
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